PACLITAXEL POLIGLUMEX | Small molecule | ovarian cancer | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
ARX-788 | Unknown | breast cancer | Tubulin inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
VINFLUNINE | Small molecule | prostate cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN | Small molecule | neoplasm | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | undifferentiated carcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | malignant peripheral nerve sheath tumor | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | ovarian clear cell adenocarcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
CROLIBULIN | Small molecule | cancer | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | urinary bladder carcinoma | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
DOLASTATIN-10 | Small molecule | sarcoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | cancer | Tubulin inhibitor | 1.0 | Withdrawn | ClinicalTrials |
DOLASTATIN-10 | Small molecule | pancreatic carcinoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
ANG1005 | Protein | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
DOLASTATIN-10 | Small molecule | gallbladder cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
VERUBULIN | Small molecule | glioblastoma multiforme | Tubulin disrupting agent | 2.0 | Completed | ClinicalTrials |
ANG1005 | Protein | brain neoplasm | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
SAGOPILONE | Small molecule | non-small cell lung carcinoma | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
PLOCABULIN | Small molecule | colorectal cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PRALUZATAMAB RAVTANSINE | Antibody | breast cancer | Tubulin inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
PLINABULIN | Small molecule | neutropenia | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
TUSAMITAMAB RAVTANSINE | Antibody | non-small cell lung carcinoma | Tubulin inhibitor | 3.0 | Recruiting | ClinicalTrials |
FOSBRETABULIN DISODIUM | Small molecule | head and neck malignant neoplasia | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
FOSBRETABULIN | Small molecule | cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | lung cancer | Tubulin stabiliser | 3.0 | Terminated | ClinicalTrials |
T-900607 | Small molecule | non-Hodgkins lymphoma | Tubulin disrupting agent | 2.0 | Terminated | ClinicalTrials |
FOSBRETABULIN | Small molecule | head and neck malignant neoplasia | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN DISODIUM | Small molecule | wet macular degeneration | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | bladder transitional cell carcinoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | breast cancer | Tubulin inhibitor | 2.0 | Withdrawn | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | Primary Peritoneal Serous Adenocarcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | peritoneum cancer | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
INDIBULIN | Small molecule | cancer | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | neuroblastoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
ARX-788 | Unknown | angiosarcoma | Tubulin inhibitor | 2.0 | Recruiting | ClinicalTrials |
SOBLIDOTIN | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Withdrawn | ClinicalTrials |
PLINABULIN | Small molecule | non-small cell lung carcinoma | Tubulin inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
DOLASTATIN-10 | Small molecule | leukemia | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | Endometrial Clear Cell Adenocarcinoma | Tubulin inhibitor | 2.0 | Withdrawn | ClinicalTrials |
DOLASTATIN-10 | Small molecule | leukemia | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
FOSBRETABULIN DISODIUM | Small molecule | head and neck malignant neoplasia | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
MILATAXEL | Small molecule | rectum cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | non-small cell lung carcinoma | Tubulin stabiliser | 2.0 | Terminated | ClinicalTrials |
VINFLUNINE | Small molecule | head and neck carcinoma | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
DOLASTATIN-10 | Small molecule | kidney cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PLINABULIN | Small molecule | non-small cell lung carcinoma | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
VERUBULIN | Small molecule | brain neoplasm | Tubulin disrupting agent | 1.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | Ovarian Transitional Cell Carcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
VINFLUNINE | Small molecule | breast cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
SAGOPILONE | Small molecule | Central Nervous System Neoplasm | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | ovarian mucinous adenocarcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
SAGOPILONE | Small molecule | glioblastoma multiforme | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
SAGOPILONE | Small molecule | small cell lung carcinoma | Tubulin stabiliser | 2.0 | Terminated | ClinicalTrials |
FOSBRETABULIN | Small molecule | wet macular degeneration | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
TUSAMITAMAB RAVTANSINE | Antibody | neoplasm | Tubulin inhibitor | 1.0 | Recruiting | ClinicalTrials |
VINFLUNINE | Small molecule | breast cancer | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | leukemia | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | Endometrial Serous Adenocarcinoma | Tubulin inhibitor | 2.0 | Withdrawn | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | synovial sarcoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
ARX-788 | Unknown | triple-negative breast cancer | Tubulin inhibitor | 2.0 | Recruiting | ClinicalTrials |
SOBLIDOTIN | Small molecule | lung cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | brain neoplasm | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN TROMETHAMINE | Small molecule | neuroendocrine neoplasm | Tubulin disrupting agent | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | fallopian tube cancer | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
SAGOPILONE | Small molecule | prostate cancer | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
TUSAMITAMAB RAVTANSINE | Antibody | non-small cell lung carcinoma | Tubulin inhibitor | 2.0 | Recruiting | ClinicalTrials |
TUSAMITAMAB RAVTANSINE | Antibody | neoplasm | Tubulin inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
FOSBRETABULIN DISODIUM | Small molecule | cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | breast cancer | Tubulin inhibitor | 1.0 | Withdrawn | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | ovarian cancer | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | non-small cell lung carcinoma | Tubulin stabiliser | 3.0 | Terminated | ClinicalTrials |
FOSBRETABULIN DISODIUM | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
PLINABULIN | Small molecule | neutropenia | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
ARX-788 | Unknown | breast cancer | Tubulin inhibitor | 2.0 | Recruiting | ClinicalTrials |
VINFLUNINE | Small molecule | small cell lung carcinoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | endometrioid carcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
VERUBULIN | Small molecule | neoplasm | Tubulin disrupting agent | 1.0 | Completed | ClinicalTrials |
PLINABULIN | Small molecule | multiple myeloma | Tubulin inhibitor | 2.0 | Recruiting | ClinicalTrials |
VINFLUNINE | Small molecule | cancer | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | urinary bladder cancer | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | Malignant Ovarian Brenner Tumor | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
DAVUNETIDE | Protein | Cognitive impairment | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN | Small molecule | neuroendocrine neoplasm | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PLOCABULIN | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
T-900607 | Small molecule | liver cancer | Tubulin disrupting agent | 2.0 | Completed | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | breast carcinoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN | Small molecule | ovarian cancer | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | breast cancer | Tubulin stabiliser | 2.0 | Withdrawn | ClinicalTrials |
VINFLUNINE | Small molecule | urogenital neoplasm | Tubulin inhibitor | 3.0 | Recruiting | ClinicalTrials |
FOSBRETABULIN | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
DOLASTATIN-10 | Small molecule | lymphoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN TROMETHAMINE | Small molecule | ovarian cancer | Tubulin disrupting agent | 2.0 | Terminated | ClinicalTrials |
LEXIBULIN | Small molecule | glioblastoma multiforme | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
DAVUNETIDE | Protein | schizophrenia | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
INDIBULIN | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Unknown status | ClinicalTrials |
VINFLUNINE | Small molecule | urogenital neoplasm | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
MILATAXEL | Small molecule | non-small cell lung carcinoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | penile neoplasm | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN | Small molecule | neuroendocrine neoplasm | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | Wilms tumor | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
ARX-788 | Unknown | breast neoplasm | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
T-900607 | Small molecule | gastric cancer | Tubulin disrupting agent | 2.0 | Completed | ClinicalTrials |
PLINABULIN | Small molecule | neutropenia | Tubulin inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | prostate adenocarcinoma | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
OMBRABULIN | Small molecule | sarcoma | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | ovarian serous adenocarcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
VINFLUNINE | Small molecule | urothelial carcinoma | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
FOSBRETABULIN | Small molecule | head and neck malignant neoplasia | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
DOLASTATIN-10 | Small molecule | ovarian cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
LEXIBULIN | Small molecule | multiple myeloma | Tubulin inhibitor | 2.0 | Terminated | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | non-small cell lung carcinoma | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | breast cancer | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
OMBRABULIN | Small molecule | ovarian cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | Fallopian Tube Serous Adenocarcinoma | Tubulin stabiliser | 3.0 | Active, not recruiting | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | endometrial cancer | Tubulin inhibitor | 2.0 | Recruiting | ClinicalTrials |
FOSBRETABULIN | Small molecule | thyroid cancer | Tubulin inhibitor | 3.0 | Withdrawn | ClinicalTrials |
VINFLUNINE | Small molecule | gastric cancer | Tubulin inhibitor | 2.0 | Terminated | ClinicalTrials |
MILATAXEL | Small molecule | mesothelioma | Tubulin inhibitor | 2.0 | Unknown status | ClinicalTrials |
SOBLIDOTIN | Small molecule | sarcoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | prostate cancer | Tubulin stabiliser | 2.0 | Terminated | ClinicalTrials |
VINFLUNINE | Small molecule | Transitional Cell Carcinoma | Tubulin inhibitor | 2.0 | Unknown status | ClinicalTrials |
SAGOPILONE | Small molecule | breast cancer | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
T-900607 | Small molecule | hepatocellular carcinoma | Tubulin disrupting agent | 2.0 | Unknown status | ClinicalTrials |
DOLASTATIN-10 | Small molecule | myelodysplastic syndrome | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
SAGOPILONE | Small molecule | neoplasm | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | non-small cell lung carcinoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
MILATAXEL | Small molecule | colonic neoplasm | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
DOLASTATIN-10 | Small molecule | malignant tumor of extrahepatic bile duct | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | squamous cell carcinoma | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | colorectal cancer | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
PLINABULIN | Small molecule | cancer | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
INDIBULIN | Small molecule | breast cancer | Tubulin inhibitor | 1.0 | Unknown status | ClinicalTrials |
OMBRABULIN | Small molecule | non-small cell lung carcinoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | breast cancer | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
FOSBRETABULIN | Small molecule | ovarian cancer | Tubulin inhibitor | 2.0 | Terminated | ClinicalTrials |
ARX-788 | Unknown | breast neoplasm | Tubulin inhibitor | 2.0 | Recruiting | ClinicalTrials |
OMBRABULIN | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
SAGOPILONE | Small molecule | small cell lung carcinoma | Tubulin stabiliser | 1.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | lung cancer | Tubulin inhibitor | 2.0 | Terminated | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | rhabdomyosarcoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
ANG1005 | Protein | glioblastoma multiforme | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
ARX-788 | Unknown | cancer | Tubulin inhibitor | 2.0 | Withdrawn | ClinicalTrials |
ANG1005 | Protein | malignant glioma | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | small cell lung carcinoma | Tubulin inhibitor | 1.0 | Terminated | ClinicalTrials |
INDIBULIN | Small molecule | neoplasm | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
SAGOPILONE | Small molecule | ovarian neoplasm | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
VINFLUNINE | Small molecule | urinary bladder cancer | Tubulin inhibitor | 1.0 | Withdrawn | ClinicalTrials |
SAGOPILONE | Small molecule | breast neoplasm | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | fallopian tube cancer | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
DOLASTATIN-10 | Small molecule | prostate cancer | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PLINABULIN | Small molecule | small cell lung carcinoma | Tubulin inhibitor | 1.0 | Recruiting | ClinicalTrials |
PACLITAXEL POLIGLUMEX | Small molecule | neoplasm | Tubulin stabiliser | 3.0 | - | ATC |
PLINABULIN | Small molecule | non-small cell lung carcinoma | Tubulin inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
SAGOPILONE | Small molecule | melanoma | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | Pleuropulmonary blastoma | Tubulin inhibitor | 2.0 | Completed | ClinicalTrials |
PLINABULIN | Small molecule | non-small cell lung carcinoma | Tubulin inhibitor | 3.0 | Completed | ClinicalTrials |
T-900607 | Small molecule | ovarian neoplasm | Tubulin disrupting agent | 2.0 | Unknown status | ClinicalTrials |
VINFLUNINE | Small molecule | neoplasm | Tubulin inhibitor | 4.0 | - | ATC |
CROLIBULIN | Small molecule | thyroid cancer | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
MIRVETUXIMAB SORAVTANSINE | Antibody | primary peritoneal carcinoma | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |
DAVUNETIDE | Protein | progressive supranuclear palsy | Tubulin stabiliser | 2.0 | Completed | ClinicalTrials |
LORVOTUZUMAB MERTANSINE | Antibody | multiple myeloma | Tubulin inhibitor | 1.0 | Completed | ClinicalTrials |